What is meso-zeaxanthin, and where does it come from?

Eye (Basingstoke)

Volumn 27, Issue 8, 2013, Pages 899-905

  Nolan, J M ^a   Meagher, K ^a   Kashani, S ^a   Beatty, S ^a  

^a South East Technological University   (Ireland)

Author keywords

Lutein; Macular Pigment; Meso zeaxanthin; Vision; Zeaxanthin

Indexed keywords

CAROTENOID; MESOZEAXANTHIN; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN;

ANTIOXIDANT ACTIVITY; BLUE LIGHT; CHEMICAL STRUCTURE; DRUG SAFETY; FOOD; HUMAN; LUMINANCE; NONHUMAN; PIGMENT EPITHELIUM; PROTEIN ANALYSIS; RETINA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; REVIEW; VISION;

EID: 84881411745     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2013.98     Document Type: Review

References (43)

1. Hirsch J, Curcio CA. The spatial resolution capacity of human foveal retina. Vision Res 1989; 29: 1095-1101.
2. Bone RA, Landrum JT, Friedes LM, Gomez CM, Kilburn MD, Menendez E et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 1997; 64: 211-218.
3. Khachik F, Bernstein PS, Garland DL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 1997; 38: 1802-1811.
4. Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment.1. absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 1984; 25: 660-673.
5. Nolan JM, Loughman J, Akkali MC, Stack J, Scanlon G, Davison P et al. The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS. Vision Res 2011; 51(5): 459-469.
6. Stringham JM, Garcia PV, Smith PA, McLin LN, Foutch BK. Macular pigment and visual performance in glare: Benefits for photostress recovery, disability glare, and visual discomfort. Invest Ophthalmol Vis Sci 2011; 52: 7406-7415.
7. Walls GL, Judd HD. The intra-ocular colour-filters of vertebrates. Br J Ophthalmol 1933; 17: 705-725.
8. Loughman J, Davison PA, Nolan JM, Akkali MC, Beatty S. Macular pigment and its contribution to visual performance and experience. J Optom 2013; 3: 74-90.
9. Beatty S, Koh HH, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45: 115-134.
10. Li B, Ahmed F, Bernstein PS. Studies on the singlet oxygen scavenging mechanism of human macular pigment. Arch Biochem Biophys 2010; 504(1): 56-60.
11. Snodderly DM, Auran JD, Delori FC. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 1984; 25: 674-685.
12. Trieschmann M, van Kuijk FJ, Alexander R, Hermans P, Luthert P, Bird AC et al. Macular pigment in the human retina: Histological evaluation of localization and distribution. Eye (Lond) 2008; 22: 132-137.
13. Li B, Vachali P, Frederick JM, Bernstein PS. Identification of StARD3 as a lutein-binding protein in the macula of the primate retina. Biochemistry 2011; 50(13): 2541-2549.
14. Bhosale P, Bernstein PS. Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation. Biochim Biophys Acta 2005; 1740: 116-121.
15. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS. Identification and characterization of a pi isoform of glutathione s-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem 2004; 279: 49447-49454.
16. Britton G. Structure and properties of carotenoids in relation to function. FASEB J 1995; 9: 1551-1558.
17. Pintea A, Rugina D, Pop R, Bunea A, Socaciu C. Xanthophylls protect against induced oxidation in cultured human retinal pigment epithelial cells. J Food Composition Anal 2011; 24: 830-836.
18. Britton G. UV/visible spectroscopy. In: Britton G, Liaaen-Jensen S, Pfander H (eds). Carotenoids: Spectroscopy Birkha?user, Basel, Switzerland; Boston, MA; Berlin, Germany, 1995; Vol. 1B, pp 13-63.
19. Davies BH. Carotenoids. In: Goodwin TW (eds). Chemistry and Biochemistry of Plant Pigments. Academic Press: London, UK, 1976; Vol. 2, pp 38-165.
20. Pease PL, Adams AJ, Nuccio E. Optical-density of human macular pigment. Vision Res 1987; 27: 705-710.
21. Rasmussen H, Muzhingi T, Eggert T, Johnson EJ. Lutein, zeaxanthin, meso-zeaxanthin content in egg yolk and their absence in fish and seafood. J Food Composition Anal 2012; 27: 139-144.
22. Sujak A, Gabrielska J, Grudzinski W, Borc R, Mazurek P, Gruszecki WI. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: The structural aspects. Arch Biochem Biophys 1999; 371: 301-307.
23. Billsten HH, Bhosale P, Yemelyanov A, Bernstein PS, Polivka T. Photophysical properties of xanthophylls in carotenoproteins from human retinas. Photochem Photobiol 2003; 78: 138-145.
24. Trevithick-Sutton CC, Foote CS, Collins M, Trevithick Jr. The retinal carotenoids zeaxanthin and lutein scavenge superoxide and hydroxyl radicals: A chemiluminescence and ESR study. Mol Vis 2006; 12: 1127-1135.
25. Junghans A, Sies H, Stahl W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys 2001; 391: 160-164.
26. Cantrell A, McGarvey DJ, Truscott TG, Rancan F, Bohm F. Singlet oxygen quenching by dietary carotenoids in a model membrane environment. Arch Biochem Biophys 2003; 412: 47-54.
27. Thurnham DI, Tremel A, Howard AN. A supplementation study in human subjects with a combination of mesozeaxanthin, (3R,30R)-zeaxanthin and (3R,30R,60R)-lutein. Br J Nutr 2008; 100: 1307-1314.
28. Bone RA, Landrum JT, Cao Y, Howard AN, varez-Calderon F. Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr Metab (Lond) 2007; 4(12): 12.
29. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional manipulation of primate retinas, III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci 2005; 46: 692-702.
30. Connolly EE, Beatty S, Loughman J, Howard AN, Louw MS, Nolan JM. Supplementation with all three macular carotenoids: Response, stability, and safety. Invest Ophthalmol Vis Sci 2011; 52: 9207-9217.
31. Khachik F, de Moura FF, Zhao DY, Aebischer CP, Bernstein PS. Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest Ophthalmol Vis Sci 2002; 43: 3383-3392.
32. Khachik F, Beecher GR, Goli MB. Separation, identification and quantification of carotenoids in fruits, vegetables and human plasma by high performance liquid chromatography. Pure Appl Chem 1991; 63: 71-80.
33. Khachik F, Beecher GR, Goli MB, Lusby WR. Separation and quantitation of carotenoids in foods. Methods Enzymol 1992; 213(347-59): 347-359.
34. Khachik F, Beecher GR, Goli MB. Separation and identification of carotenoids of carotenoids and their oxidation products in the extracts of human plasma. Anal Chem 1992; 64: 2111-2122.
35. Bone RA, Landrum JT, Hime GW, Cains A, Zamor J. Stereochemistry of the Human Macular Carotenoids. Invest Ophthalmol Vis Sci 1993; 34: 2033-2040.
36. Perry AF, Rasmussen HM, Johnson EJ. Xanthophyll (lutein, zeaxanthin) content in fruits, vegetables and corn and egg products. J Food Composition Anal 2009; 22: 9-15.
37. Maoka T, Arai A, Shimizu M, Matsuno T. The first isolation of enantiomeric and meso-zeaxanthin in nature. Comp Biochem Physiol B 1986; 83: 121-124.
38. Meagher KA, Thurnham DI, Beatty S, Howard AN, Connolly E, Cummins W et al. Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration. Br J Nutr 2012; 1-12.
39. Bhosale P, Serban B, Zhao dY, Bernstein PS. Identification and metabolic transformations of carotenoids in ocular tissues of the Japanese quail Coturnix japonica. Biochemistry 2007; 46: 9050-9057.
40. Connolly EE, Beatty S, Thurnham DI, Loughman J, Howard AN, Stack J et al. Augmentation of macular pigment following supplementation with all three macular carotenoids: An exploratory study. Curr Eye Res 2010; 35: 335-351.
41. Nolan JM, Akkali MC, Loughman J, Howard AN, Beatty S. Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. Exp Eye Res 2012; 101: 9-15.
42. Chang CJG. Thirteen week oral (gavage) toxicity of meso-zeaxanthin in HanWister rats with a 4-week recovery. Gene Logic Laboratories, Inc.: Gaithersburg, MD, 2006, Study no. 1567-04370.
43. Xu X, Zhang L, Shao B, Sun X, Ho CT, Li S. Safety evaluation of meso-zeaxanthin. Food Control 2013; 32: 678-686.